BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9527714)

  • 1. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic factors in the pathogenesis of Alzheimer's disease: roles of beta-amyloid and presenilins].
    Iwatsubo T; Tomita T
    Tanpakushitsu Kakusan Koso; 1998 Oct; 43(13):1963-72. PubMed ID: 9789459
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and genetics of Alzheimer disease].
    Myhre A; Tysnes OB
    Tidsskr Nor Laegeforen; 2002 Jan; 122(1):50-3. PubMed ID: 11851296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteins of Alzheimer's disease].
    Piekiełko A
    Postepy Biochem; 1999; 45(2):116-22. PubMed ID: 10581635
    [No Abstract]   [Full Text] [Related]  

  • 9. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum.
    Dermaut B; Kumar-Singh S; Rademakers R; Theuns J; Cruts M; Van Broeckhoven C
    Trends Genet; 2005 Dec; 21(12):664-72. PubMed ID: 16221505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell biology of the beta-amyloid precursor protein and the genetics of Alzheimer's disease.
    Selkoe DJ
    Cold Spring Harb Symp Quant Biol; 1996; 61():587-96. PubMed ID: 9246485
    [No Abstract]   [Full Text] [Related]  

  • 14. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease or Alzheimer's diseases? Clues from molecular epidemiology.
    Hyman BT
    Ann Neurol; 1996 Aug; 40(2):135-6. PubMed ID: 8773592
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
    Iwatsubo T
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular physiopathology of Alzheimer's disease].
    Yamada T
    Fukuoka Igaku Zasshi; 1998 Feb; 89(2):29-33. PubMed ID: 9549175
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances fuel Alzheimer's conundrum.
    Mattson MP
    Nat Genet; 1997 Nov; 17(3):254-6. PubMed ID: 9354778
    [No Abstract]   [Full Text] [Related]  

  • 19. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
    Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.